Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM
· Real-Time Price · USD
3.22
-0.13 (-3.88%)
At close: Aug 15, 2025, 3:59 PM
3.28
1.63%
After-hours: Aug 15, 2025, 07:36 PM EDT
Psyence Biomedical Income Statement
Financials in USD. Fiscal
year is
undefined.
Fiscal Year | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
Period Ending | Sep 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -1.7M | -2.47M | -2.35M | -1.96M | -1.74M | -1.29M | -1.04M | -919.78K | -626.76K | -299.86K | -45.06K |
Interest Income | 187.84K | 673.45K | 3.3M | 4.1M | 4.03M | 3.55M | 923.53K | 124.26K | 8.71K | 2.42K | n/a |
Pretax Income | -25.33M | -25.5M | 1.52M | 2.93M | 5.04M | 8.01M | 14.07M | 13.26M | 11.22M | 8.26M | -45.06K |
Net Income | -25.33M | -25.5M | 1.52M | 2.93M | 5.04M | 8.01M | 14.07M | 13.26M | 11.22M | 8.26M | -45.06K |
Selling & General & Admin | 2.52M | 2.4M | 2.35M | 1.96M | 1.74M | 1.29M | 1.04M | 919.77K | 626.75K | 299.85K | 45.06K |
Research & Development | 340.76K | 75.14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 1.02K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 2.86M | 2.47M | 2.35M | 1.96M | 1.74M | 1.29M | 1.04M | 919.77K | 626.75K | 299.85K | 45.06K |
Interest Expense | 3.71K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 314.07K | 40.31K | 1.08K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.86M | 2.47M | 2.35M | 1.96M | 1.74M | 1.29M | 1.04M | 919.77K | 626.75K | 299.85K | 45.06K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 276.73K | 13.39M | 7.69M | 8.04M | 11.43M | 32.67M | 28.54M | 28.54M | 28.54M | 32.67M | 32.75M |
Shares Outstanding (Diluted) | 276.73K | 13.39M | 7.69M | 8.04M | 11.43M | 32.67M | 28.54M | 28.54M | 28.54M | 32.67M | 32.75M |
EPS (Basic) | 36.41 | -1.94 | -0.03 | 0.09 | 0.17 | 0.27 | 0.45 | 0.42 | 0.35 | 0.25 | -0.00 |
EPS (Diluted) | 36.40 | -1.94 | -0.03 | 0.09 | 0.17 | 0.27 | 0.45 | 0.42 | 0.35 | 0.25 | -0.00 |
EBITDA | -1.56M | -2.47M | -2.35M | -1.96M | -1.74M | -1.29M | -1.04M | -919.78K | -626.76K | -299.86K | -45.06K |
EBIT | -723.72K | -893.4K | -1.56M | -1.63M | 480.46K | 3.46M | 13.06M | 13.26M | 11.22M | 8.26M | -45.06K |
Depreciation & Amortization | 1.14K | 120.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |